secwatch / observer
8-K filed December 21, 2023, 6:59 PM ET ticker FRMM CIK 0001690080
leadership confidence high sentiment negative materiality 0.80

Five directors resign from 180 Life Sciences board over cost-cutting dispute

FORUM MARKETS Inc

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Larry Gold

Director
FRMM · FORUM MARKETS Inc
Effective
2023-12-17
Filed
December 21, 2023, 6:59 PM ET
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
Departed

Russell Ray

Director
FRMM · FORUM MARKETS Inc
Effective
2023-12-17
Filed
December 21, 2023, 6:59 PM ET
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
Departed

Pam Marrone

Director
FRMM · FORUM MARKETS Inc
Effective
2023-12-17
Filed
December 21, 2023, 6:59 PM ET
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
Departed

Francis Knuettel II

Director
FRMM · FORUM MARKETS Inc
Effective
2023-12-17
Filed
December 21, 2023, 6:59 PM ET
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
Departed

Teresa DeLuca

Director
FRMM · FORUM MARKETS Inc
Effective
2023-12-17
Filed
December 21, 2023, 6:59 PM ET
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Larry Gold resigned as Director at FORUM MARKETS Inc.

Action
resigned
Role
Director
Exact text from the filing
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Russell Ray resigned as Director at FORUM MARKETS Inc.

Action
resigned
Role
Director
Exact text from the filing
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Pam Marrone resigned as Director at FORUM MARKETS Inc.

Action
resigned
Role
Director
Exact text from the filing
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Francis Knuettel II resigned as Director at FORUM MARKETS Inc.

Action
resigned
Role
Director
Exact text from the filing
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Teresa DeLuca resigned as Director at FORUM MARKETS Inc.

Action
resigned
Role
Director
Exact text from the filing
Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp.
View on SEC.gov

FORUM MARKETS Inc filing history →

Source: SEC EDGAR
accession 0001213900-23-097741
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.